Mek'ele | inhibitor | Acetylcholinesterase inhibitor | Selective serotonin reuptake inhibitor | MEK | Enzyme inhibitor | enzyme inhibitor | Westermoen Båtbyggeri og Mek Verksted | Metalloprotease inhibitor | Matrix metalloproteinase inhibitor | Inhibitor | Farnesyltransferase inhibitor | COX-2 inhibitor | ALK inhibitor | ACE inhibitor |
Cobimetinib (GDC-0973, XL-518) is a MEK inhibitor being developed by Exelixis and Roche.